Supplement for Ligand discovery for delineating cholesterol homeostasis in the brain
用于描述大脑胆固醇稳态的配体发现的补充
基本信息
- 批准号:10613677
- 负责人:
- 金额:$ 34.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAdultAffectAgingAreaBehavioralBiologicalBiological MarkersBrainCholesterolCholesterol HomeostasisDataDementiaDeteriorationDiseaseEvaluationFunctional disorderGoalsHIVHIV InfectionsHIV-1Imaging DeviceImmunohistochemistryImpaired cognitionImpairmentInfectionKnowledgeLigandsModelingMolecularMonitorN-MethylaspartateNeurocognitiveNeuroimmuneNeuroimmune systemNeurologicNeuronsOutcomePathogenesisPathway interactionsPatientsPhasePhysiologicalPositron-Emission TomographyProcessProteinsRattusResearchRodent ModelScienceSignal TransductionSurrogate MarkersSynapsesSystemTimeTracerTransgenic OrganismsUnited StatesUnited States National Institutes of HealthValidationWestern Blottingbrain tissuedesignexcitotoxicityexperimental studyin vivolipid disorderlongitudinal positron emission tomographymolecular imagingmotor symptomneuroimagingneuroinflammationnovelnovel diagnosticspre-clinicalsynaptic functiontreatment strategyuptakeyoung adult
项目摘要
Project Summary: HIV-1 is the causative agent of acquired immunodeficiency syndrome (AIDS), which is a
multi-system disorder including the CNS. Neurological impairment affects approximately 60% of HIV-infected
patients. HIV-1 enters the CNS at the early phase of infection, persists in that system for decades and induces
multiple symptoms of motor, cognitive dysfunction and behavioral changes. Recently it has been estimated that
nearly 30% of adults infected with HIV are affected. In the United States, HIV-1 infection is the most common
cause of dementia in young adults. The more subtle forms of neurocognitive dysfunction however became more
prevalent, leading to gradual, but ultimately significant functional deterioration of otherwise virologically controlled
HIV+ patients.
Among various factors, excitotoxic damage, neuroimmune dysfunction, lipid disorders and synaptic function
are major factors in the HIV progression and aging process. Although all these remarkable discoveries have
been made in the understanding of HIV-1 infection in the CNS at the molecular level via ex vivo (destructive)
analysis, it cannot be directly applied to most brain tissues in vivo. Non-invasive PET neuroimaging approach
can fill this void and provide direct and real-time correlation of aforementioned important signaling activity in the
infected brain, facilitating novel HIV-1 neurotherapies. Therefore, we envision to directly monitor excitotoxicity
(target: GluN2B-NMDA subtype), neuroinflammation (P2X7), cholesterol (CTP46A1) and synaptic (SV2A)
function by PET as surrogate biomarkers in vivo in the brain of HIV-1 transgenic rat models. We speculate that
longitudinal PET imaging of four distinct molecular imaging pathways will not only provide novel diagnostics to
guide treatment strategies, but also study underlying mechanism of long-term HIV disease and aging,
dysfunctional neuroimmune system as highlighted in the “Key NIH HIV Research Areas FY 2021-2025”.
项目概述:HIV-1是获得性免疫缺陷综合征(AIDS)的病原体,
包括CNS在内的多系统疾病。神经功能障碍影响约60%的艾滋病毒感染者
患者HIV-1在感染的早期阶段进入CNS,在该系统中持续数十年,并诱导
运动、认知功能障碍和行为改变的多种症状。最近据估计,
近30%的成年艾滋病毒感染者受到影响。在美国,HIV-1感染是最常见的
导致年轻人痴呆的原因然而,神经认知功能障碍的更微妙形式变得更加复杂。
流行,导致逐渐的,但最终显着的功能恶化,否则病毒控制
艾滋病毒+患者。
在众多因素中,兴奋性毒性损伤、神经免疫功能障碍、脂质紊乱和突触功能
是艾滋病毒进展和衰老过程中的主要因素。尽管所有这些非凡的发现
通过体外(破坏性)在分子水平上了解CNS中的HIV-1感染
分析,它不能直接应用于体内的大多数脑组织。非侵入性PET神经成像方法
可以填补这一空白,并提供直接和实时的相关性,上述重要的信号活动,
感染的大脑,促进新的HIV-1神经疗法。因此,我们设想直接监测兴奋性毒性,
(靶点:GluN 2B-NMDA亚型)、神经炎症(P2 X7)、胆固醇(CTP 46 A1)和突触(SV 2A)
在HIV-1转基因大鼠模型的脑中,通过PET作为体内替代生物标志物发挥作用。我们推测
四种不同分子成像途径的纵向PET成像将不仅提供新的诊断,
指导治疗策略,但也研究长期艾滋病毒疾病和衰老的潜在机制,
功能失调的神经免疫系统,如“2021-2025财年NIH HIV关键研究领域”所强调的那样。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven H Liang其他文献
Ru-Photoredox-Catalyzed Decarboxylative Oxygenation of Aliphatic Carboxylic Acids through N-(acyloxy)phthalimide
Ru-光氧化还原催化 N-(酰氧基)邻苯二甲酰亚胺对脂肪族羧酸进行脱羧氧化
- DOI:
10.1021/acs.orglett.8b01885 - 发表时间:
2018 - 期刊:
- 影响因子:5.2
- 作者:
Chao Zheng;Yuting Wang;Yangrui Xu;Zhen Chen;Guangying Chen;Steven H Liang - 通讯作者:
Steven H Liang
Steven H Liang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven H Liang', 18)}}的其他基金
Subtype-Selective Metabotropic Glutamate Receptor PET Ligands
亚型选择性代谢型谷氨酸受体 PET 配体
- 批准号:
10576674 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Glycogen synthase kinase 3 ligand discovery for Alzheimer’s disease
糖原合成酶激酶 3 配体发现治疗阿尔茨海默病
- 批准号:
10637434 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Subtype-selective phosphodiesterase PET ligands
亚型选择性磷酸二酯酶 PET 配体
- 批准号:
10568308 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Subtype-selective NMDA ligands for Alzheimer's Disease
阿尔茨海默病的亚型选择性 NMDA 配体
- 批准号:
10593906 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
In vivo Probe for ionotropic glutamate signaling system: AMPA receptors
离子型谷氨酸信号系统体内探针:AMPA 受体
- 批准号:
10584340 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
Subtype-selective NMDA ligands for Alzheimer's Disease
阿尔茨海默病的亚型选择性 NMDA 配体
- 批准号:
10355691 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10641669 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
PET imaging of ionotropic glutamate receptor signaling in Alzheimer's disease
阿尔茨海默病中离子型谷氨酸受体信号传导的 PET 成像
- 批准号:
10574694 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10356395 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
PET Imaging for neuroinflammation in Alzheimer's disease
阿尔茨海默病神经炎症的 PET 成像
- 批准号:
10653556 - 财政年份:2022
- 资助金额:
$ 34.93万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 34.93万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 34.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




